(Q38024285)

27 August 2017

title

Vitamin D and multiple sclerosis: a critical review and recommendations on treatment (English)

1 reference

27 August 2017

0 references

0 references

Mohammad Ali Sahraian

object named as

Mohammad Ali Sahraian

series ordinal

3

0 references

Amirreza Azimi

series ordinal

5

object named as

Amirreza Azimi

1 reference

27 August 2017

2

Ghazaleh Eskandari

1 reference

27 August 2017

1

Alireza Faridar

1 reference

27 August 2017

Alireza Minagar

4

1 reference

27 August 2017

language of work or name

1 reference

6 July 2012

1 reference

27 August 2017

published in

Acta Neurologica Belgica

1 reference

27 August 2017

volume

112

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

327-333

1 reference

https://scigraph.springernature.com/pub.10.1007/s13760-012-0108-z

27 August 2017

exact match

0 references

cites work

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Environmental factors and their timing in adult-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Vitamin D and autoimmunity: new aetiological and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Vitamin D: criteria for safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Vitamin D in preventive medicine: are we ignoring the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Vitamin D deficiency and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Vitamin D: more than just affecting calcium and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Assessment of evidence for a protective role of vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

UVR, vitamin D and three autoimmune diseases--multiple sclerosis, type 1 diabetes, rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Immunomodulatory actions of 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Vitamin D and autoimmune disease--implications for practice from the multiple sclerosis literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Clinical implications of a possible role of vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Immunomodulatory effects of Vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

The geographic distribution of multiple sclerosis: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Multiple sclerosis in North Norway, and first appearance in an indigenous population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Seasonal, gestational and postnatal influences on multiple sclerosis: the beneficial role of a vitamin D supplementation during early life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Ultraviolet immunosuppression: mechanisms and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Gestational vitamin D and the risk of multiple sclerosis in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Dietary intake of vitamin D during adolescence and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Monthly ambient sunlight, infections and relapse rates in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Vitamin D deficiency: the time to ignore it has passed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Estimates of optimal vitamin D status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0108-Z

10.1007/S13760-012-0108-Z

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference